These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3502613)

  • 1. Is the indirect antiglobulin crossmatch justified?
    Peterson DM; Roxby DJ; Seshadri R
    Pathology; 1987 Apr; 19(2):121-3. PubMed ID: 3502613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reappraisal of pre-transfusion testing procedures in a hospital blood bank.
    Lown JA; Barr AL; Jackson JM
    Pathology; 1985 Jul; 17(3):489-92. PubMed ID: 4069768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and cost-containment data that advocate abbreviated pretransfusion testing.
    Cordle DG; Strauss RG; Snyder EL; Floss AM
    Am J Clin Pathol; 1990 Oct; 94(4):428-31. PubMed ID: 2220670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransfusion testing without serologic crossmatch: approaches to ensure patient safety.
    Kuriyan M; Fox E
    Vox Sang; 2000; 78(2):113-8. PubMed ID: 10765147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a manual hexadimethrine bromide-antiglobulin test with saline- and albumin-antiglobulin tests for pretransfusion testing.
    Mintz PD; Anderson G
    Transfusion; 1987; 27(2):134-7. PubMed ID: 3824470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative utility of the autologous control and the antiglobulin test phase of the crossmatch.
    Perkins JT; Arruza M; Fong K; Sosler SD; Saporito C
    Transfusion; 1990; 30(6):503-7. PubMed ID: 2378021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and Post-Transfusion Alloimmunization in Dogs Characterized by 2 Antiglobulin-Enhanced Cross-match Tests.
    Goy-Thollot I; Giger U; Boisvineau C; Perrin R; Guidetti M; Chaprier B; Barthélemy A; Pouzot-Nevoret C; Canard B
    J Vet Intern Med; 2017 Sep; 31(5):1420-1429. PubMed ID: 28804957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization.
    Dinardo CL; Bonifácio SL; Mendrone A
    Immunohematology; 2014; 30(1):1-5. PubMed ID: 25238242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch?
    Lee E; Redman M; Burgess G; Win N
    Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.
    Pinkerton PH; Coovadia AS; Goldstein J
    Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the polyethyleneglycol antiglobulin test in the detection and identification of erythrocyte antibodies].
    Jiménez Marco MT; Hernández Maraver D; Rodríguez de la Rua A; de la Cámara Mendizábal C; Canales Albendea M; Jiménez Yuste V; Hernández Navarro F
    Sangre (Barc); 1998 Feb; 43(1):21-4. PubMed ID: 9577178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.
    Judd WJ; Barnes BA; Steiner EA; Oberman HA; Averill DB; Butch SH
    Transfusion; 1986; 26(3):220-4. PubMed ID: 3705135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the crossmatch in testing for serologic incompatibility.
    Oberman HA; Barnes BA; Steiner EA
    Transfusion; 1982; 22(1):12-6. PubMed ID: 6801826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hemolytic reaction implicating Sda antibody missed by immediate spin crossmatch.
    Reznicek MJ; Cordle DG; Strauss RG
    Vox Sang; 1992; 62(3):173-5. PubMed ID: 1609519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three low-ionic-strength solutions for routine pretransfusion testing: antibody screening/identification, cross-matching, immune anti-ABO detection, and direct antiglobulin tests.
    Kaspi E; Mallié F; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
    Transfusion; 2009 Dec; 49(12):2772-3. PubMed ID: 20163691
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with the routine use of an abbreviated crossmatch.
    Shulman IA; Nelson JM; Saxena S; Thompson JC; Okamoto M; Kent DR; Nakayama RK
    Am J Clin Pathol; 1984 Aug; 82(2):178-81. PubMed ID: 6465079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of the "group-and-screen" for the full crossmatch in elective operations.
    Kelton JG; Perrault RA; Blajchman MA
    Can Anaesth Soc J; 1983 Nov; 30(6):641-5. PubMed ID: 6640401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3 new antibody detection tests. A comparative study].
    Mempel W; Alraun K; Leeping M; Kirschner M; Reiser H; Heim MU
    Beitr Infusionsther; 1990; 26():362-6. PubMed ID: 1703872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-stage papain-indirect antiglobulin test and LISS direct agglutination are not appropriate for pretransfusion screening for unexpected antibodies.
    Pereira A; Mazzara R; Gelabert A; Castillo R
    Haematologica; 1991; 76(6):475-8. PubMed ID: 1820984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.